상품명칭 |
Bleomycinamide, N1-[3-(디메틸설포니오)프로필]- |
별명 |
; Bleomycinamide, n1-(3-(디메틸설포니오)프로필)-; N1- (3- (디메틸 설포니오) 프로필) 블레오마이신아마이드; UNII-13M89UEA7W; 정광마이신 A2; Zhengguangmycin A2 [중국어]; (3-{[(2'-{(5S,8S,9S,10R,13S)-15-{6-아미노-2-[(1S)-3-아미노-1-{[(2S)-2,3-디아미노-3-옥소프로필]아미노}-3-옥소프로필]-5-메틸피리미딘-4-일}-13-[(R)-{[(2R,3S,4S,5S,6S)-3-{[(2R,3S,4S,5R,6R)-4-(카르바모일옥시)-3,5-디하이드록시-6-(하이드록시메틸)테트라하이드로-2H-피란-2-일]옥시}-4,5-디하이드록시-6-(하이드록시메틸)테트라하이드로-2H-피란-2-일]옥시}(1H-이미다졸-5-일)메틸]-9-하이드록시-5-[(1R)-1-하이드록시에틸]-8,10-디메틸-4,7,12,15-테트라옥소-3, 6,11,14-테트라아자펜타덱-1-일}-2,4'-바이-1,3-티아졸-4-일)카르보닐]아미노}프로필)(디메틸)술포늄(비-바람직한 명칭) |
영문 이름 |
Bleomycinamide, N1-[3-(dimethylsulfonio)propyl]-; Bleomycinamide, n1-(3-(dimethylsulfonio)propyl)-; N1-(3-(Dimethylsulfonio)propyl)bleomycinamide; UNII-13M89UEA7W; Zhengguangmycin A2; Zhengguangmycin A2 [Chinese]; (3-{[(2'-{(5S,8S,9S,10R,13S)-15-{6-amino-2-[(1S)-3-amino-1-{[(2S)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl]-5-methylpyrimidin-4-yl}-13-[(R)-{[(2R,3S,4S,5S,6S)-3-{[(2R,3S,4S,5R,6R)-4-(carbamoyloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}(1H-imidazol-5-yl)methyl]-9-hydroxy-5-[(1R)-1-hydroxyethyl]-8,10-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazapentadec-1-yl}-2,4'-bi-1,3-thiazol-4-yl)carbonyl]amino}propyl)(dimethyl)sulfonium (non-preferred name) |
분자식 |
C55H84N17O21S3 |
분자량 |
1415.5512 |
InChI |
InChI=1/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1 |
cas번호 |
11116-31-7 |
EC번호 |
234-356-5 |
분자 구조 |
|
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|